Abstract
Berlin Heart EXCOR® (BHE) ventricular assist device (VAD) (Berlin Heart, Berlin Heart AG, Berlin, Germany) implantation is prevalent in patients with severe heart failure. However, clinical outcomes of pediatric patients on long-term BHE support remain mainly unknown. This study aimed to report our clinical experience with long-term support of pediatric patients with severe heart failure supported by BHE VAD. Clinical outcomes of 11 patients (median age 8.4 months; two male), who underwent LVAD implantation of the Berlin Heart EXCO® (BHE) VAD (Berlin Heart, Berlin Heart AG, Berlin, Germany) between 2013 and 2017 at our institution were reviewed. The median support period was 312 (range 45–661) days and five patients were supported for more than 1 year. The longest support duration was 661 days. No mortality occurred, and six patients were successfully bridged to heart transplantation, while three patients were successfully weaned off the device. Two patients are currently on BHE support while they await heart transplantation. Four patients had cerebral bleeding or infarction, but only one case of persistent neurological deficit occurred. No fatal device-related infection occurred during LVAD support. BHE VAD can provide long-term support for pediatric patients with severe heart failure with acceptable mortality and morbidity rates with long-term support.
Similar content being viewed by others
References
Hetzer R, Kaufmann F, Delmo Walter EM (2016) Paediatric mechanical circulatory support with Berlin Heart EXCOR: development and outcome of a 23-year experience. Eur J Cardiothorac Surg 50(2):203–210
Conway J et al (2015) Delineating survival outcomes in children %3c10 kg bridged to transplant or recovery with the Berlin Heart EXCOR Ventricular Assist Device. JACC Heart Fail 3(1):70–77
Hetzer R et al (2006) Mechanical cardiac support in the young with the Berlin Heart EXCOR pulsatile ventricular assist device: 15 years' experience. Semin Thorac Cardiovasc Surg 9(1):99–108
Hetzer R et al (2011) Single-center experience with treatment of cardiogenic shock in children by pediatric ventricular assist devices. J Thorac Cardiovasc Surg 141(3):616–623
Di Molfetta A et al (2016) The use of Berlin Heart EXCOR VAD in children less than 10 kg: a single center experience. Front Physiol 7:614
Almond CS et al (2011) Berlin Heart EXCOR Pediatric ventricular assist device investigational Device Exemption study: Study design and rationale. Am Hear J 162(3):425–435
Isojima T et al (2016) Growth standard charts for Japanese children with mean and standard deviation (SD) values based on the year 2000 national survey. Clin Pediatr Endcrinol. 25(2):71–76
Almond CS et al (2013) Berlin Heart EXCOR pediatric ventricular assist device for bridge to heart transplantation in US children. Circulation 127(16):1702–1711
Morales DLS et al (2017) Berlin Heart EXCOR use in patients with congenital heart disease. J Heart Lung Transplant 36(11):1209–1216
Byrnes JW et al (2013) Incremental reduction in the incidence of stroke in children supported with the Berlin EXCOR ventricular assist device. Ann Thorac Surg 96(5):1727–1733
Miera O et al (2014) Pump size of Berlin Heart EXCOR pediatric device influences clinical outcome in children. J Heart Lung Transplant 33(8):816–821
Jordan LC et al (2015) Neurological complications and outcomes in the Berlin Heart EXCOR(R) pediatric investigational device exemption trial. J Am Heart Assoc 4(1):e001429
Zafar F et al (2015) Biventricular Berlin heart EXCOR pediatric use across the United States. Ann Thorac Surg 99(4):1328–1334
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors has any financial relationship related to this manuscript to disclose.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kanaya, T., Ueno, T., Taira, M. et al. Impact of Long-Term Support with Berlin Heart EXCOR® in Pediatric Patients with Severe Heart Failure. Pediatr Cardiol 40, 1126–1133 (2019). https://doi.org/10.1007/s00246-019-02108-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-019-02108-0